Takeda Pharmaceutical Co. (TAK) vs Teva Pharmaceutical Industries Ltd. (TEVA)
- Takeda Pharmaceutical Co. TAK 19.67 +1.13%
- Teva Pharmaceutical Industries Ltd. TEVA 41.52 +1.00%
Takeda Pharmaceutical Co. and Teva Pharmaceutical Industries Ltd. are both Drug Manufacturers Specialty & Generic companies. Takeda Pharmaceutical Co. is the larger, with a market value of $61.9B against $47.9B — 1.3× the size. Takeda Pharmaceutical Co. trades at the lower P/E: 29.6× against 65.9×. Teva Pharmaceutical Industries Ltd. grew revenue faster over the last twelve months: 4.13% against 0.66%. Takeda Pharmaceutical Co. has the higher net margin (7.12% vs 4.08%) and the lower return on invested capital (2.88% vs 4.58%). Across the 21 metrics below, Takeda Pharmaceutical Co. leads on 15 and Teva Pharmaceutical Industries Ltd. on 6.
Valuation
Profitability
| Metric | TAK | TEVA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 65.85% | 52.46% | 53.94% |
| Operating margin | 11.61% | 8.77% | 0.00% |
| Net margin | 7.12% | 4.08% | 0.00% |
| Free cash flow margin | 24.74% | 8.09% | 0.00% |
| Return on equity | 4.42% | 9.69% | (0.40%) |
| Return on assets | 2.15% | 1.77% | (3.32%) |
| Return on invested capital | 2.88% | 4.58% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack